Current stage-Stage I (Early) Posts on Medivizor
Navigation Menu

Current stage-Stage I (Early) Posts on Medivizor

How effective is rituximab, bendamustine, mitoxantrone (R-BM) and rituximab consolidation as a treatment regimen for elderly patients with advanced follicular lymphoma?

How effective is rituximab, bendamustine, mitoxantrone (R-BM) and rituximab consolidation as a treatment regimen for elderly patients with advanced follicular lymphoma?

Posted by on Feb 14, 2021 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study aimed to investigate if rituximab (Rituxan), bendamustine (Treanda), and mitoxantrone (Novantrone) or R-BM followed by rituximab consolidation was a safe and effective treatment in older patients with follicular lymphoma (FL). The authors concluded that this treatment provided durable responses and was well tolerated in...

Read More

The effectiveness of chemotherapy and radiotherapy in nodular lymphocyte predominant Hodgkin lymphoma depending on disease stage

The effectiveness of chemotherapy and radiotherapy in nodular lymphocyte predominant Hodgkin lymphoma depending on disease stage

Posted by on Dec 31, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This study aimed to investigate the effectiveness of chemotherapy and radiotherapy (CRT) in patients with nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL).  This study concluded that combined CRT may be more effective in patients with early-stage NLPHL, particularly in older patients.  Some background...

Read More

Looking for patients with follicular lymphoma to trial an experimental treatment.

Looking for patients with follicular lymphoma to trial an experimental treatment.

Posted by on Aug 30, 2020 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This trial is looking to assess the effectiveness of ME-401 for relapsed follicular lymphoma (FL) after the failure of two or more therapies. The main outcome to be measured in this trial is the percentage of patients whose cancer shrinks or disappears after treatment.  The details FL is a type of non-Hodgkin lymphoma....

Read More

Does tumor size affect long-term outcomes after treatment for patients with early-stage Hodgkin lymphoma?

Posted by on Apr 7, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This study evaluated whether tumor size affected treatment outcomes for patients with early-stage (ES) Hodgkin lymphoma (HL). This study concluded that the risk of cancer recurrence increased with increasing tumor size. Some background PET scanning during treatment is used to guide therapy for patients with HL. Depending on the scan...

Read More

Is radiotherapy after chemotherapy associated with late side effects in patients with Hodgkin’s lymphoma?

Posted by on Nov 3, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This study evaluated the long-term outcomes of chemotherapy plus radiotherapy for patients with early-stage classical Hodgkin's lymphoma (cHL). The authors found that this treatment combination was highly effective, with minimal late side effects. Some background Early-stage (stage 1 to 2) cHL is usually treated with a...

Read More

Can PET scanning help guide treatment for patients with Hodgkin’s lymphoma?

Posted by on Oct 13, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This study evaluated whether PET scanning after chemotherapy might help predict outcomes and guide treatment for patients with early-stage Hodgkin's lymphoma (HL). This study found that PET scanning can help identify high-risk patients after chemotherapy. Some background Chemotherapy combined with radiotherapy is the standard of...

Read More

Evaluating A+AVD chemotherapy for patients with early-stage Hodgkin lymphoma

Posted by on Jul 8, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This study evaluated the effectiveness and safety of a modified chemotherapy regimen for patients with early-stage Hodgkin lymphoma (HL). This study concluded that this regimen was effective but associated with more side effects. Some background The most commonly used frontline chemotherapy regimen for HL is ABVD (doxorubicin,...

Read More

Searching for patients with relapsed or unresponsive follicular lymphoma to trial a new drug

Posted by on Apr 24, 2019 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This trial will evaluate the effects of a new treatment parsaclisib (INCB050465) in relapsed or unresponsive follicular lymphoma (FL). Response rate, survival, and side effects will be the main outcomes measured. The details Many patients are cured with treatments for follicular lymphoma (FL). Some, however, lose response to therapy...

Read More

Low-dose radiotherapy for low-grade lymphoma: What are the outcomes?

Posted by on Mar 17, 2018 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study investigated the effectiveness, side effects, and relapse patterns of patients with low-grade (indolent; painless) follicular lymphoma (FL) or marginal zone lymphoma (MZL) after low-dose radiotherapy (LDRT). This study concluded that LDRT is an effective treatment in patients with low-grade disease and a low tumor burden. Some...

Read More